Medicine
Temodar 250 mg capsule
Temodar 250 mg capsule is a prescription medicine containing Temozolomide for oral use, marketed by Merck Sharp & Dohme, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store TEMODAR for injection refrigerated at 2°C to 8°C (36°F to 46°F). Store…
Key facts
- Active ingredient (INN)
- Temozolomide
- Brand
- Temodar
- Strength
- 250 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 5 packets
- Marketing authorisation holder
- Merck Sharp & Dohme
- Manufacturer
- Merck Sharp & Dohme
- Origin register
- US FDA, United States
- Storage
- Store TEMODAR for injection refrigerated at 2°C to 8°C (36°F to 46°F). Store TEMODAR Capsules at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01AX03 Temozolomide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 11 August 1999
- Identifiers
- RxCUI 261288, 261289, 261290 +7DailyMed set ID 046a9011-3911-4d3f-a15f-fbb56d5aad56NDC 0085-1417Application NDA021029
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 packet in 1 carton / 1 capsule in 1 packet | 0085-1417-02 | Merck Sharp & Dohme | 11 August 1999 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Temozolomide 250 mg capsule.
Other strengths and forms of Temozolomide
Clinical summary
Temozolomide is an alkylating drug indicated for the treatment of adults with newly diagnosed glioblastoma concomitantly with radiotherapy and then as maintenance treatment, among other approved uses. MedsAcross supplies Temozolomide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TemozolomideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TEMODAR prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
- Temodal: European public assessment report (EPAR) · European Medicines Agency
- Temomedac: European public assessment report (EPAR) · European Medicines Agency
Need Temodar 250 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.